New Screen Process for Oral Cancers
Posted on: Friday, 19 January 2007, 12:00 CST
Patients with early-stage oral cancer may benefit from an advanced screening process allowing for a more accurate diagnosis, according to a U.S. study.
By combining conventional techniques with more modern techniques, we were able to better diagnose and determine the best options for patients with oral cancer, said lead author J.B. Epstein of the University of Illinois at Chicago.
This approach to diagnosing oral cancer may lead to easier identification of serious pathology, significantly lessening the need for unnecessary biopsies without additional risk of false negatives.
Doctors in this study used chemiluminescent light, a pharmaceutical grade dye used in addition to the conventional visual and manual observations of the patient.
This study found that of the 84 patients studied, the dye improved either the brightness or sharpness of the identified lesions by 61 percent. Only biopsying lesions that retained the toluidine blue stain reduced the false-positive rate by nearly 59 percent while maintaining zero false negatives.
The findings were presented at the Multidisciplinary Head and Neck Cancer Symposium in Rancho Mirage, Calif.
Source: United Press International
Related Articles
- Epigenomics Reports Positive Results From Prostate Cancer Study
- CuraGen Initiates Phase II Breast Cancer Study
- Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
- Aradigm Announces Data Showing No Occurrence of Primary Lung Cancer in Patients Treated With AERx(R) Insulin Diabetes Management System (iDMS)
- Progen Presents Positive Data From Phase II Liver Cancer Study
- Progen Presents Additional Analysis of Data From PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
- Merck Serono Has Initiated the ONWARD Study to Evaluate Oral Cladribine As Add-on Treatment for Multiple Sclerosis
- Valeant Pharmaceuticals Announces Availability of Complimentary ``Managing Chemotherapy Side Effects For Dummies'' Cancer Chemotherapy Resource; Special Edition ``For Dummies''(R) Book Now Available for Cancer Chemotherapy Patients and Caregivers
- Blood test may find early lung cancer: study
- Endpoints Met in First Stage of ADVENTRX CoFactor Phase II Metastatic Colorectal Cancer Study; Patient Enrollment Completed in Phase II Study
User Comments (0)

RSS Feeds